These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3938097)

  • 1. [Interactions between monoaminergic neurons projecting to the cerebral cortex].
    Descarries L; Ferron A; Reader TA; de Montigny C
    Union Med Can; 1985 Dec; 114(12):964-8, 973. PubMed ID: 3938097
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors--current status.
    Zemishlany Z; Radwan M; Wijsenbeek H
    Isr J Psychiatry Relat Sci; 1983; 20(3):254-71. PubMed ID: 6325369
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of monoamine oxidase inhibitors and serotonin reuptake inhibitors on 3H-serotonin receptor binding in rat brain.
    Savage DD; Frazer A; Mendels J
    Eur J Pharmacol; 1979 Sep; 58(1):87-8. PubMed ID: 315323
    [No Abstract]   [Full Text] [Related]  

  • 6. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible, enzyme-activated monoamine oxidase inhibitors: new advances.
    Da Prada M; Kettler R; Cesura AM; Richards JG
    Pharmacol Res Commun; 1988 Dec; 20 Suppl 4():21-33. PubMed ID: 3149747
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors.
    Blier P; de Montigny C
    Neuroscience; 1985 Dec; 16(4):949-55. PubMed ID: 3005914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant drugs: effects on beta-adrenergic and serotonineregic receptors.
    Frazer A; Lucki I
    Adv Biochem Psychopharmacol; 1982; 31():69-90. PubMed ID: 6282067
    [No Abstract]   [Full Text] [Related]  

  • 11. The sensitivity of cortical neurons to serotonin: effect of chronic treatment with antidepressants, serotonin-uptake inhibitors and monoamine-oxidase-blocking drugs.
    Olpe HR; Schellenberg A
    J Neural Transm; 1981; 51(3-4):233-44. PubMed ID: 6793695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline.
    Sharma U; Roberts ES; Hollenberg PF
    Drug Metab Dispos; 1996 Jun; 24(6):669-75. PubMed ID: 8781784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the type A and type B monoamine oxidase. A new approach to their development and subcellular localization.
    Yu PH; Hertz L
    Mod Probl Pharmacopsychiatry; 1983; 19():177-88. PubMed ID: 6408406
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of antidepressants in use in the United States.
    Richelson E
    J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):4-13. PubMed ID: 7174631
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
    Kitanaka N; Kitanaka J; Takemura M
    Neuroscience; 2005; 130(2):295-308. PubMed ID: 15664686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of terminal 5-HT autoreceptors by 5-HT reuptake blockers.
    de Montigny C; Blier P
    Arch Gen Psychiatry; 1991 May; 48(5):483-4. PubMed ID: 2021304
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on amiflamine, a reversible inhibitor of monoamine oxidase type A, selective for serotonergic neurons.
    Ask AL
    Acta Pharm Suec; 1983; 20(6):473. PubMed ID: 6675426
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of the interaction of serotonin- and noradrenergic systems in regulating behavior].
    Semenova TP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(2):358-61. PubMed ID: 9173740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.